Human papillomavirus E6 regulates the cytoskeleton dynamics of keratinocytes through targeted degradation of p53

Journal of Virology

Volumn 81, Issue 22, 2007, Pages 12675-12679

  Cooper, Brooke ^a   Brimer, Nicole ^a   Vande Pol, Scott B ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; INTEGRIN; PROTEIN E6; PROTEIN P53; UBIQUITIN PROTEIN LIGASE;

ALLELE; ARTICLE; CELL SPREADING; CELL SURFACE; CONTROLLED STUDY; CYTOSKELETON; E6 GENE; EXTRACELLULAR MATRIX; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HYDROPHOBICITY; KERATINOCYTE; NONHUMAN; PAPILLOMA VIRUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; UTERINE CERVIX; VIRUS ADSORPTION; VIRUS GENE; WART VIRUS;

CELL MOVEMENT; CELLS, CULTURED; CYTOSKELETON; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

BOVINE PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 36048974622     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01083-07     Document Type: Article

References (29)

1. Allen-Hoffmann, B. L., S. J. Schlosser, C. A. Ivarie, C. A. Sattler, L. F. Meisner, and S. L. O'Connor. 2000. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J. Investig. Dermatol. 114:444-455.
2. Brimer, N., C. Lyons, and S. B. Vande Pol. 2007. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein. Virology 358:303-310.
3. Cooper, B., S. Schneider, J. Bohl, Y. Jiang, A. Beaudet, and S. Vande Pol. 2003. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 306:87-99.
4. Grm, H. S., and L. Banks. 2004. Degradation of hDIg and MAGIs by human papillomavirus E6 is E6-AP-independent. J. Gen. Virol. 85:2815-2819.
5. Handa, K., T. Yugawa, M. Narisawa-Saito, S. Ohno, M. Fujita, and T. Kiyono. 2007. E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J. Virol. 81:1379-1389.
6. Hasskarl, J., P. Velupillai, S. O. Piboonniyom, M. Grace, and K. Munger. 2005. Long-term maintenance of human keratinocytes in vitro. J. Investig. Dermatol. 124:475-478.
7. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:4129-4135.
8. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13:4918-4927.
9. Jing, M., J. Bohl, N. Brimer, M. Kinter, and S. B. Vande Pol. 2007. Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins. J. Virol. 81:2231-2239.
10. Kuballa, P., K. Matentzoglu, and M. Scheffner. 2007. The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J. Biol. Chem. 282:65-71.
11. 11. Lagrange, M., S. Charbonnier, G. Orfanoudakis, P. Robinson, K. Zanier, M. Massen, Y. Lutz, G. Trave, E. Weiss, and F. Deryckere. 2005. Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6. J. Gen. Virol. 86:1001-1007.
12. Matsumoto, Y., S. Nakagawa, T. Yano, S. Takizawa, K. Nagasaka, K. Nakagawa, T. Minaguchi, O. Wada, H. Ooishi, K. Matsumoto, T. Yasugi, T. Kanda, J. M. Huibregtse, and Y. Taketani. 2006. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6. J. Med. Virol. 78:501-507.
13. McCormack, S. J., S. E. Brazinski, J. L. Moore, Jr., B. A. Werness, and D. J. Goldstein. 1997. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene 15:265-274.
14. Münger, K., A. Baldwin, K. M. Edwards, H. Hayakawa, C. L. Nguyen, M. Owens, M. Grace, and K. Huh. 2004. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78:11451-11460.
15. Nakagawa, S., and J. M. Huibregtse. 2000. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20:8244-8253.
16. Pim, D., M. Thomas, and L. Banks. 2002. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins. Oncogene 21:8140-8148.
17. Pim, D., M. Thomas, R. Javier, D. Gardiol, and L. Banks. 2000. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19:719-725.
18. Rheinwald, J. G., and H. Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-343.
19. Rheinwald, J. G., W. C. Hahn, M. R. Ramsey, J. Y. Wu, Z. Guo, H. Tsao, M. De Luca, C. Catricala, and K. M. O'Toole. 2002. A two-stage, p16(INK4A)-and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell. Biol. 22:5157-5172.
20. Ridley, A. J., M. A. Schwartz, K. Burridge, R. A. Firtel, M. H. Ginsberg, G. Borisy, J. T. Parsons, and A. R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science 302:1704-1709.
21. Roger, L., G. Gadea, and P. Roux. 2006. Control of cell migration: a tumour suppressor function for p53? Biol. Cell. 98:141-152.
22. Scheffner, M., J. M. Huibregtse, R. D. Vierstra, and P. M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
23. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholder, et al. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
24. Shai, A., M. L. Nguyen, J. Wagstaff, Y. H. Jiang, and P. F. Lamhert. 2007. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. Oncogene 26:3321-3328.
25. Shaulian, E., A. Zauberman, D. Ginsberg, and M. Oren. 1992. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12:5581-5592.
26. Tong, X., and P. M. Howley. 1997. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl. Acad. Sci. USA 94:4412-4417.
27. Vande Pol, S. B., M. C. Brown, and C. E. Turner. 1998. Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16:43-52.
28. Wade, R., J. Bohl, and S. Vande Pol. 2002. Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene 21:96-107.
29. Wade, R., and S. Vande Pol. 2006. Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinase. Biochem. J. 393:565-573.